Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Journal of Drugs in Dermatology : JDD|January 6, 2023
Sixty Years of Benzoyl Peroxide Use in DermatologyHilary Baldwin, Boni Elewski, Firas Hougeir, et al.The Journal of Clinical and Aesthetic Dermatology|June 18, 2016
Fixed Combination Aerosol Foam Calcipotriene 0.005% (Cal) Plus Betamethasone Dipropionate 0.064% (BD) is More Efficacious than Cal or BD Aerosol Foam Alone for Psoriasis Vulgaris: A Randomized, Double-blind, Multicenter, Three-arm, Phase 2 StudyMark Lebwohl, Stephen Tyring, Michael Bukhalo, et al.Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|June 19, 2004
Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group studyNicholas Lowe, Michael Gifford, Emil Tanghetti, et al.Journal of Drugs in Dermatology : JDD|August 19, 2016
The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST StudyCraig Leonardi, Jerry Bagel, Paul Yamauchi, et al.Journal of Drugs in Dermatology : JDD|December 15, 2015
Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST)Craig Leonardi, Jerry Bagel, Paul Yamauchi, et al.Journal of Drugs in Dermatology : JDD|February 8, 2022
Intralesional Mode of Drug Administration in PsoriasisSuja Sathyan, Komal Agarwal, Indrashis Podder, et al.Journal of Drugs in Dermatology : JDD|February 8, 2022
Treatment of Nail PsoriasisMartin Kassir, Leon Kircik, Jeffrey Weinberg, et al.The British Journal of Dermatology|October 23, 2024
Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded active-controlled comparative clinical study over 52 weeksAndrew Blauvelt, Kim Papp, Mona Trivedi, et al.Advances in Therapy|September 23, 2020
PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in PsoriasisLinda Stein Gold, Javier Alonso-Llamazares, Jean-Philippe Lacour, et al.Journal of the American Academy of Dermatology|May 12, 2023
Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trialJerry Bagel, Linda Stein Gold, James Del Rosso, et al.Pageof 3